Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
layoffs
Biotech
Mass. biotechs bring in VC dollars but see workforce shrink
A new report on the health of the Massachusetts biotech scene has painted a mixed picture of how drug developers are faring in the Bay State.
Will Maddox
Aug 25, 2026 5:00am
Kolon TissueGene shrinks workforce after pivotal trial miss
Aug 18, 2026 4:00pm
Fierce Biotech Layoff Tracker 2026: Kolon, Sanofi & more
Aug 18, 2026 9:40am
Merck KGaA makes further cuts to US research team
Aug 17, 2026 1:23pm
Aura drops headcount by 20%, rejigs C-suite amid R&D refocusing
Aug 11, 2026 8:17am
Arpeggio Bio disbands after Nrf2 program starts to ‘unravel’
Aug 10, 2026 5:04am
